Ikarian Capital’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $117K | Hold |
27,257
| – | – | 0.02% | 91 |
|
|
2025
Q1 | $102K | Sell |
27,257
-3
| -0% | -$11 | 0.01% | 107 |
|
|
2024
Q4 | $277K | Sell |
27,260
-30
| -0.1% | -$304 | 0.04% | 98 |
|
|
2024
Q3 | $340K | Hold |
27,290
| – | – | 0.05% | 79 |
|
|
2024
Q2 | $355K | Hold |
27,290
| – | – | 0.06% | 76 |
|
|
2024
Q1 | $618K | Buy |
27,290
+623
| +2% | +$14.1K | 0.07% | 66 |
|
|
2023
Q4 | $346K | Hold |
26,667
| – | – | 0.03% | 68 |
|
|
2023
Q3 | $536K | Hold |
26,667
| – | – | 0.06% | 59 |
|
|
2023
Q2 | $716K | Buy |
26,667
+6,667
| +33% | +$179K | 0.11% | 53 |
|
|
2023
Q1 | $1.17M | Buy |
+20,000
| New | +$1.17M | 0.26% | 46 |
|
|
2022
Q2 | – | Sell |
-55
| Closed | -$6K | – | 130 |
|
|
2022
Q1 | $6K | Buy |
55
+3
| +6% | +$327 | ﹤0.01% | 152 |
|
|
2021
Q4 | $5K | Buy |
+52
| New | +$5K | ﹤0.01% | 147 |
|
|
2021
Q2 | – | Sell |
-53
| Closed | -$9K | – | 194 |
|
|
2021
Q1 | $9K | Hold |
53
| – | – | ﹤0.01% | 177 |
|
|
2020
Q4 | $12K | Buy |
+53
| New | +$12K | ﹤0.01% | 131 |
|
|
2020
Q2 | – | Sell |
-2,428
| Closed | -$700K | – | 109 |
|
|
2020
Q1 | $700K | Buy |
+2,428
| New | +$700K | 0.05% | 55 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 71 |
|